Journal of Innovation in Cardiac Rhythm Management

Latest News

shadow-div-content

Milestone Pharmaceuticals Announces Submission of New Drug Application to the U.S. FDA for Etripamil

Read more...

New Biosense Webster QDOT MICRO™ Catheter Data Demonstrate Very High-Power, Short-Duration Ablations Improved Quality of Life and Reduced Healthcare Utilization for AFib Patients

Read more...

Pulsecare Medical’s nsPFA Clinical Trial Receives Satisfactory Short-term Follow-up Results

Read more...

Yiling Pharmaceutical’s Shensong Yangxin Capsules Have Obtained Registration in Nigeria—Study Has Shown that It Significantly Improves the Prognosis of Patients After Radiofrequency Ablation

Read more...

Cadrenal Therapeutics Highlights Additional Need for a New Vitamin K Antagonist (Tecarfarin) Following Updates from the Recent European Society of Cardiology Congress

Read more...

More Articles...